Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

Not-for-profit hospitals see revenue growth tumble

U.S. not-for-profit hospitals’ revenue growth hit an all-time low of 3.9 percent in 2013, Moody’s Investor Services calculated, with little relief in sight for 2014.

Novel anticoagulants vs. warfarin: Popular but pricey

Novel oral anticoagulants have outstripped warfarin for usage in the U.S., but at a price. A study found that the three new options for treating patients with atrial fibrillation made up 62 percent of new prescriptions but cost $900 higher than warfarin after six months.

Thumbnail

A peek at TCT headliner? Keynote takes on GME funding

Could this be a preview of a keynote speech at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C.? In an assay, economist Uwe E. Reinhardt, PhD, argued that graduate medical education (GME) did not meet the standards for receiving federal funding.

Thumbnail

Leaping lipids! Common test costs $10 to $10,000 in California

Buyers beware. Hospitals in California charged as little as $10 and as much as $10,169 for a lipid panel test, according to an analysis published Aug. 15 in BMJ Open.

Cardiology pay slips 8% but who, what & where makes difference

Overall compensation for cardiologists dropped almost 8 percent between 2012 and 2013 but the pain was not spread evenly, according to MedAxiom’s annual survey. Pay and pay cuts varied greatly depending on subspecialty, employment model and region.

GAO: Few strategies to prevent heart disease provide cost savings

The U.S. Government Accountability Office (GAO) ruled that a number of treatments to prevent cardiovascular disease were either not cost effective or offered no cost savings in a report released Aug. 11.

Pay-for-performance model sputters over long term

A pay-for-performance model in England failed to show much sustained improvement in 30-day mortality for heart failure (HF) and acute MI (AMI), in spite of incentives and penalties, according to a study published online Aug. 7 in the New England Journal of Medicine.

CMS approves CardioMEMS, MitraClip for add-on payments

The Centers for Medicare & Medicaid Services (CMS) agreed to provide some reimbursement for the CardioMEMS heart failure and MitraClip valve devices beginning in fiscal year 2015.

Displaying 1417 - 1424 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.